Abstract
Clinical tolerance, defined as discontinuation of immunosuppression without immunological events, is often achieved after allogeneic hematopoietic stem cell transplantation, unlike after organ transplantation. However, this phenomenon has rarely been studied. Between September 1977 and December 1997, we evaluated 354 allogeneic hematopoietic stem cell recipients who had had more than 1 year of relapse-free survival, regarding time to discontinuation of immunosuppression. Factors such as patient age, donor age, donor sex, immunosuppressive protocols, cell dose, and graft-versus-host-disease (GVHD) were studied. Patients who did not develop GVHD had discontinued immunosuppression according to the protocols, within 1 year for malignant diseases and within 2 years for nonmalignant diseases. Patients given methotrexate as a single drug were off immunosuppression faster than those given cyclosporine alone (P=0.05). Children (<18 years) discontinued immunosuppression faster than adults (P=0.05). Low donor age was of greater importance than low recipient age for early discontinuation (P=0.003). Male recipients of stem cells from immunized female donors needed a longer time to discontinuation (P<0.001). Patients without acute GVHD had a...Continue Reading
References
Apr 17, 1975·The New England Journal of Medicine·E ThomasC D Buckner
Apr 24, 1975·The New England Journal of Medicine·E D ThomasC D Buckner
Feb 1, 1991·Transplantation·P G BeattyE M Mickelson
Jun 1, 1991·Transplantation·D WeisdorfA Filipovich
Jan 1, 1991·Bone·R B Martin, S L Zissimos
Mar 1, 1990·Transplantation·G SocieE Gluckman
Aug 1, 1989·British Journal of Haematology·R StorbJ Hansen
Oct 1, 1988·Transplantation·L BoströmB Nilsson
Apr 9, 1988·Lancet·G B VogelsangT Chen
Dec 1, 1987·British Journal of Haematology·R P GaleJ H Kersey
Mar 20, 1986·The New England Journal of Medicine·R StorbV Farewell
Jan 1, 1985·Journal of the American Academy of Dermatology·S R HymesG W Santos
Mar 1, 1970·Transplantation·R StorbE D Thomas
Jan 1, 1983·Acta Radiologica. Oncology·O RingdénB Lönnqvist
Sep 1, 1994·Blood Reviews·M Siadak, K M Sullivan
Oct 27, 1994·Transplantation·O RingdénL Markling
Jul 1, 1993·European Journal of Haematology·O Ringdén
Nov 1, 1995·Bone·R W NorrdinM A Thrall
Dec 1, 1996·Immunology Today·T E StarzlA S Rao
Jul 15, 1997·Transplantation·D P BesnierV L Esnault
Jun 1, 1997·Leukemia & Lymphoma·V RoyD Weisdorf
May 7, 1998·Leukemia & Lymphoma·R M LemoliS Tura
Sep 2, 1998·Transplantation Proceedings·D H Sachs
Sep 30, 1998·Transplantation·O RingdénP Ljungman
Nov 25, 1998·Bone Marrow Transplantation·S CarlensJ Aschan
Dec 5, 1998·Transplantation Proceedings·T E Starzl
Feb 19, 1999·Theoretical Medicine and Bioethics·T E Starzl, A J Demetris
Sep 22, 1999·Bone Marrow Transplantation·S CarlensO Ringdén
Jan 5, 2000·Clinical Transplantation·J AschanM Remberger
Feb 16, 2000·Leukemia·J MattssonH Zetterquist
May 16, 2000·Bone Marrow Transplantation·H ZetterquistO Ringdén
Mar 10, 2001·Transplantation·J MattssonO Ringdén
Citations
May 24, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Vanessa HowardMary Ellen Conley
Sep 1, 2009·Bone Marrow Transplantation·K GilliJ Mattsson
Oct 31, 2003·Transplantation·Olle RingdénOuti Hovatta
Nov 30, 2005·Transplantation·Thomas O KleenMary J Laughlin
Mar 2, 2006·Annals of Plastic Surgery·Selahattin OzmenMaria Siemionow
Dec 27, 2005·The Journal of Surgical Research·Junji OkayamaYoshiyuki Nakajima